PS-159-Intestinal dysbiosis fuels liver disease progression via NLRP3 in the Mdr2−/− mouse model of primary sclerosing cholangitis

MLA

Christian Liedtke, et al. “PS-159-Intestinal Dysbiosis Fuels Liver Disease Progression via NLRP3 in the Mdr2−/− Mouse Model of Primary Sclerosing Cholangitis.” Journal of Hepatology, vol. 70, Apr. 2019, p. e100. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a6b89bfc9ac5d0e6b8382246faf4bf88&authtype=sso&custid=ns315887.

APA

Christian Liedtke, M. Frissen, Anika Nier, Till Strowig, Maximilian Hatting, Antje Mohs, Peng Jin, Annika Wahlström, Thomas Longerich, Lijun Liao, Galvez Eric, J Hennings, Francisco Javier Cubero, Philip Puchas, Huan Sun, Johannes Haybäck, Christian Trautwein, Kai Markus Schneider, Ina Bergheim, … Hanns-Ulrich Marschall. (2019). PS-159-Intestinal dysbiosis fuels liver disease progression via NLRP3 in the Mdr2−/− mouse model of primary sclerosing cholangitis. Journal of Hepatology, 70, e100.

Chicago

Christian Liedtke, M. Frissen, Anika Nier, Till Strowig, Maximilian Hatting, Antje Mohs, Peng Jin, et al. 2019. “PS-159-Intestinal Dysbiosis Fuels Liver Disease Progression via NLRP3 in the Mdr2−/− Mouse Model of Primary Sclerosing Cholangitis.” Journal of Hepatology 70 (April): e100. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a6b89bfc9ac5d0e6b8382246faf4bf88&authtype=sso&custid=ns315887.